Aging process in the human body is greatly influenced by the action of free radicals (byproducts of our own metabolism), but can be slowed down without the need to consume special dietary supplements if the HGF protein production, naturally found in the liver, is increased.
This same protein helps to stop and reverse the destruction of the organ caused by cirrhosis, alcoholic liver disease or the consumption of drugs against tuberculosis like Isoniazid or Rifampicin.
Mexican scientists form the Metropolitan Autonomous University (UAM) discovered the antioxidant effects of the HGF protein and also proved in their laboratory its liver regenerating effects. These effects had been planted as hypothesis by other research groups across the world, but had never been successfully tested.
This findings set the base to build a new line of therapeutic attention to stop the premature aging of the human body caused by exposure to different toxins, like alcohol. The next challenge for the research group at UAM is to develop a method to make the liver increase or decrease the production of the HGF protein because it cannot be eaten or ingested as a common drug.
“What we discovered was not a new antioxidant, like vitamin C that can be found in orange juice or dietary supplements. What we discovered was the action of a liver produced protein that turns on, regulates and modulates the natural defense mechanisms of our body against free radicals”, Luis Enrique Gómez Quiroz, head of the project, explained during the interview.
Mexican research started on 2006 and has counted with the collaboration of the Laboratory of Experimental Carcinogenesis form the National Cancer Institute of the United States.
HGF stands for Hepatocytes (type of cell that composes the main tissue of the liver) Growth Factor which was identified 35 years ago in Japan but its anti-aging effects were discovered in Mexico City.
This research group also proved, in mice with cirrhosis, that when HGF levels are low the disease advances at a rapid pace and that it stops when this protein is present at a higher concentration.
“HGF turns on routes to produce natural antioxidant compounds in our body, for example a small tripeptide (a molecule composed by three amino acids, which work as construction bricks in our body) called glutathione which works as a very important antioxidant and liver protector.
“We have seen in this laboratory that HGF notably increases the production of glutathione and other protector compounds, not just for the liver, but for all the organs in the body: lungs, kidneys, pancreas, etc. When this natural antioxidant is induced to increase its production, it protects the body from the toxic effects of many compounds like alcohols”, said Gómez Quiroz.
Go deeper with Bing News on:
- UPMC Memorial opens liver transplant clinic in Yorkon January 13, 2021 at 6:50 am
UPMC Liver Transplant Evaluation Clinic at UPMC Memorial is opening this week for south central Pennsylvanians with liver disease.
- UPMC Opens York Liver Transplant Clinicon January 13, 2021 at 6:20 am
YORK, Pa. – South central Pennsylvanians with end-stage liver disease now have a new option for liver transplant evaluation with the opening this week ...
- Biotechnology e-Symposium in Delhi: Impacts on human healthon January 7, 2021 at 2:04 am
Biotechnology plays a definitive role in meeting the unmet medical needs and the advancement of the healthcare sector by bringing innovative new technologies an ...
- High hopes as Inventiva takes NASH contender into phase 3on January 6, 2021 at 5:12 am
Analysts are continuing to back Inventiva’s lanifibranor as a potential “best-in-class” drug for the fatty liver disease NASH, as the company prepares for the launch of a phase 3 trial in spring.
- Leading $105M biotech funding, Bayer deepens cell therapy investmenton January 6, 2021 at 4:08 am
A Series B investment in Senti Biosciences will support the startup's research on off-the-shelf candidates, as Bayer places another bet on cell therapy.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- AVEO Oncology Highlights Recent Progress and 2021 Outlookon January 8, 2021 at 3:21 am
AVEO Oncology (Nasdaq: AVEO) today highlighted its recent progress and outlined its 2021 outlook. We remain keenly focused on building out our commercial team ahead of the potential U.S. launch of ...
- Evolving Concepts of Liver Fibrogenesis Provide New Diagnostic and Therapeutic Optionson January 6, 2021 at 4:01 pm
HGF - hepatocyte growth factor; IGF - insulin-like growth factor; KGF - keratinocyte growth factor; LTBP - latent TGF-β binding protein; MCP - monocyte chemotactic peptide; MIP - macrophage ...
- Deciphering Genetic Disease in the Genomic Era: The Model of GnRH Deficiencyon January 1, 2021 at 4:00 pm
These candidates will then need to be filtered by cross-referencing basic science–derived biological information, including messenger RNA and protein expression profiles, mouse knockout models, cell ...
- Protein Biomarkers for Amyotrophic Lateral Sclerosison December 25, 2020 at 4:00 pm
These proteins, EPO, HGF, MCP-1, NFL, neurofilament heavy subunit, Cys C and TTR, represent the best described protein biomarkers for ALS in CSF to date. From these biomarkers, it is not possible ...
- DeepMind Protein Folding & Patenting AI Inventionson December 22, 2020 at 6:28 pm
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.